The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
XtalPi announced an expansion of its research collaboration with Pfizer to pioneer a next-generation molecular modeling platform for drug discovery. ...
read more
Novartis Canada announced that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib tablets) in combination with an ...
read more
Aitia announced a collaboration with Gustave Roussy, a cancer research institute in Europe. The new partners will collaborate to transform Gustave ...
read more
Halozyme Therapeutics announced that Bristol Myers Squibb received European Commission (EC) approval of a new Opdivo® (nivolumab) subcutaneous ...
read more
The FDA has approved Brekiya (dihydroergotamine mesylate) injection, marking a significant advancement in the acute treatment of migraine and cluster ...
read more
Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and ...
read more
Colorcon has announced an exclusive partnership with ASHA Cellulose, a provider of organo-soluble Ethyl cellulose polymers widely used in the ...
read more
Rigaku Corporation and SPERA PHARMA have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by ...
read more
Halozyme Therapeutics, Inc. announced that argenx has received FDA approval of VYVGART® Hytrulo prefilled syringe for self-injection (efgartigimod ...
read more
Signios Biosciences announced its rebranding from its previous identity as the US based research division of MedGenome Inc. This milestone marks a new...
read more
Wednesday, April 09, 2025
Orexo AB announced positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate formulated with the AmorphOX technology.
read more
Wednesday, March 26, 2025
GV20 Therapeutics (GV20) has entered into a strategic research collaboration with Mitsubishi Tanabe Pharma Corporation (MTPC). Under this ...
read more
AIM Vaccine Co. has recently received approval from the FDA to begin clinical trials for two major mRNA vaccine products: the mRNA shingles vaccine ...
read more
Wednesday, February 26, 2025
ImmunoPrecise Antibodies Ltd. (IPA) announced a strategic collaboration with RIBOPRO, a provider of mRNA and lipid nanoparticle (LNP) technologies. ...
read more
Thursday, January 30, 2025
Breckenridge Pharmaceutical, Inc., announced that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral ...
read more